Quantum Discovery Labs » tuberculosis http://q-pharm.com The drug discovery company Fri, 03 Feb 2012 10:47:43 +0000 en hourly 1 http://wordpress.org/?v=3.2.1 QP42 in-vitro efficacy summary (MDR, XDR strains, other drugs/drug candidates) http://q-pharm.com/2010/12/qp42-in-vitro-efficacy-summary-mdr-xdr-strains-other-drugsdrug-candidates/ http://q-pharm.com/2010/12/qp42-in-vitro-efficacy-summary-mdr-xdr-strains-other-drugsdrug-candidates/#comments Tue, 21 Dec 2010 17:00:23 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=355
  • Bactericidal activity study of the newest anti-tuberculosis compound QP-42 completed
  • Quantum tests a novel targeted anti-tuberculosis compound
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2010/12/qp42-in-vitro-efficacy-summary-mdr-xdr-strains-other-drugsdrug-candidates/feed/ 0     Bactericidal activity study of the newest anti-tuberculosis compound QP-42 completed http://q-pharm.com/2010/06/bactericidal-activity-study-of-the-newest-anti-tuberculosis-compound-qp-42-completed/ http://q-pharm.com/2010/06/bactericidal-activity-study-of-the-newest-anti-tuberculosis-compound-qp-42-completed/#comments Mon, 14 Jun 2010 04:56:20 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=275
  • Quantum tests a novel targeted anti-tuberculosis compound
  • QP42 in-vitro efficacy summary (MDR, XDR strains, other drugs/drug candidates)
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2010/06/bactericidal-activity-study-of-the-newest-anti-tuberculosis-compound-qp-42-completed/feed/ 0     Quantum tests a novel targeted anti-tuberculosis compound http://q-pharm.com/2010/06/quantum-tests-a-novel-targeted-anti-tuberculosis-compound/ http://q-pharm.com/2010/06/quantum-tests-a-novel-targeted-anti-tuberculosis-compound/#comments Sat, 05 Jun 2010 09:39:31 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=268
  • Bactericidal activity study of the newest anti-tuberculosis compound QP-42 completed
  • QP42 in-vitro efficacy summary (MDR, XDR strains, other drugs/drug candidates)
  • New inhibitors of RecA (bacterial SOS response system) identified.
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2010/06/quantum-tests-a-novel-targeted-anti-tuberculosis-compound/feed/ 0     ISTC/NIH-NIAID meeting, Moscow, 17.11.09 http://q-pharm.com/2009/11/istcnih-niaid-meeting-moscow-17-11-09/ http://q-pharm.com/2009/11/istcnih-niaid-meeting-moscow-17-11-09/#comments Tue, 17 Nov 2009 18:59:10 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=148
  • Quantum and Tibotec Pharmaceuticals enter antiviral drug discovery collabortaion.
  • Quantum tests a novel targeted anti-tuberculosis compound
  • HIV-1 integrase drug discovery collaboration
  • Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.
  • Quantum and MOLECMO Nanobiotechnologies announce collaboration.
    • Related posts brought to you by Yet Another Related Posts Plugin.]]>     http://q-pharm.com/2009/11/istcnih-niaid-meeting-moscow-17-11-09/feed/ 0